Home > Healthcare > Medical Devices > Diagnostic Devices > In-vitro Diagnostics Market
In-vitro Diagnostics Market Share
- Report ID: GMI2820
- Published Date: Mar 2023
- Report Format: PDF
In-vitro Diagnostics Market Share
- Abbott, BioMerieux SA
- Becton
- Dickinson
- and Company, F. Hoffman - La Roche AG
- Danaher Corporation
- Sysmex Corporation
- Thermo Fischer Scientific
- DiaSorin
- Bio-Rad Laboratories, Inc.
- Ortho Clinical Diagnostics (QuidelOrtho),
- Qiagen
- and Siemens Healthineers
are some of the key participants involved in the market. These firms are engaging in production capacity expansion and portfolio diversification tactics to stay ahead in the competitive landscape.
Frequently Asked Questions (FAQ) :
Global market for in-vitro diagnostics recorded a valuation of more than USD 101 billion in 2022 and is primed to progress at a 3.5% CAGR between 2023 and 2032 propelled by surging incidences of chronic diseases such as blood pressure, other heart ailments, and lifestyle diseases globally.
Hematology segment is poised to grow at more than 4% CAGR from 2023 to 2032 as a result of their crucial role in the diagnosis and management of the COVID-19 illness.
In-vitro diagnostics market from infectious diseases application segment is anticipated to be valued at over USD 42 billion by 2032 owing to the demand for rapid diagnostic tests to identify and contain outbreaks.
North America market is slated to grow at more than 3% CAGR over 2023-2032 on account of escalating adoption of in-vitro diagnostics and supportive improvements in healthcare infrastructure in the region.
In-vitro Diagnostics Market Scope
×
Get a free sample of
In-vitro Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below